Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Tullow Oil merger talks with Meren Energy said to have collapsed

(Sharecast News) - Talks about a possible merger between Tullow Oil and Canadian-listed peer Meren Energy have reportedly collapsed. According to Sky News, discussions about a tie-up were progressing as recently as this month but are now said to have been terminated.

Sky said it was unclear on Tuesday evening what the reason was for the abandonment of the negotiations.

Last December, Tullow Oil - which has a market valuation of about £275m - saw merger talks involving Kosmos Energy fall apart.

Meren Energy, which until recently was called Africa Oil Corp, is substantially larger than Tullow Oil in valuation terms.

Listed in Canada and Sweden, it has a market capitalisation equivalent to about £980m.

Meren recently said it had up to $500m to spend on acquiring producing assets in Africa.

At 0828 BST, Tullow shares were down 7.5% at 19.80p.

Commenting on the Sky report, Shore Capital analyst James Hosie said: "We suspect Tullow's ongoing debt refinancing plans were an obstacle to any deal being agreed, while recent oil price volatility and the path to securing government and regulatory approvals in Ghana may also make agreeing terms and completing a transaction challenging.

"However, it is also an indication that industry peers see value in Tullow's core Ghanaian production assets."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.